Dr. Tom Biernacki, DPM, FACFAS

Semaglutide and tirzepatide work — but they’re not magic. Dr. Tom explains GLP-1 receptor agonists, who they’re right for, and what happens metabolically when you stop.

Hyperoside (quercetin-3-galactoside) reduces oxidative stress in peripheral nerves by activating the Nrf2/HO-1 pathway. Dr. Tom reviews its evidence in diabetic neuropathy models.

Magnesium deficiency is found in 50% of migraine patients. Dr. Tom’s evidence-based protocol covers magnesium glycinate, riboflavin 400mg, CoQ10, and the metabolic triggers most neurologists miss.

Explore the 9 hallmarks of aging — senolytics, NAD+, mTOR, rapamycin — and the evidence-based protocols Dr. Tom uses to slow biological aging and extend healthspan.

Wogonin, a flavone from Scutellaria baicalensis, suppresses microglial NLRP3 activation and reduces pain hypersensitivity in diabetic neuropathy. Dr. Tom reviews its anti-neuroinflammatory evidence.

Up to 84% of ADHD children are iron deficient. Dr. Tom explains the ferritin threshold, omega-3 DHA dosing, and the functional medicine workup that actually addresses root causes.

CoQ10 improves egg quality and sperm motility in clinical studies. Dr. Tom’s preconception protocol covers mitochondrial support, methylation, and evidence-based supplement timing.

6.9 million Americans have Alzheimer’s. Dr. Tom breaks down the ReCODE protocol, APOE4 testing, BDNF, and 36 metabolic drivers of cognitive decline you can act on now.

Pterostilbene, a methylated resveratrol analog with superior bioavailability, activates SIRT1, reduces HbA1c, and protects peripheral nerves. Dr. Tom reviews its evidence in diabetic neuropathy.

LDL cholesterol misses most heart attack risk. Dr. Tom explains ApoB, Lp(a), and coronary artery calcium scoring — the tests that actually predict cardiovascular events.